Volume 82, Issue 11, Pages (December 2012)

Slides:



Advertisements
Similar presentations
Telomerase deficiency delays renal recovery in mice after ischemia–reperfusion injury by impairing autophagy Huifang Cheng, Xiaofeng Fan, William E. Lawson,
Advertisements

Volume 78, Issue 11, Pages (December 2010)
Volume 67, Issue 2, Pages (February 2005)
Volume 65, Issue 1, Pages (January 2004)
Volume 68, Issue 4, Pages (October 2005)
Volume 80, Issue 1, Pages (July 2011)
Volume 63, Issue 6, Pages (June 2003)
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
Volume 81, Issue 11, Pages (June 2012)
Volume 85, Issue 3, Pages (March 2014)
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
Volume 76, Issue 8, Pages (October 2009)
Volume 76, Issue 11, Pages (December 2009)
Volume 62, Issue 2, Pages (August 2002)
Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule–specific knockout mouse models  Qingqing Wei, Guie Dong,
Volume 76, Issue 11, Pages (December 2009)
From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria  Paul E. De Jong, Barry M. Brenner  Kidney International 
Volume 72, Issue 4, Pages (August 2007)
Critical role for osteopontin in diabetic nephropathy
Volume 78, Issue 9, Pages (November 2010)
Volume 83, Issue 5, Pages (May 2013)
Volume 65, Issue 1, Pages (January 2004)
Volume 68, Issue 5, Pages (November 2005)
Volume 58, Issue 6, Pages (December 2000)
The kallikrein–kinin system in diabetic nephropathy
Volume 63, Issue 4, Pages (April 2003)
Volume 84, Issue 5, Pages (November 2013)
Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
Mukut Sharma, Ellen T. Mccarthy, Virginia J. Savin, Elias A. Lianos 
Volume 69, Issue 3, Pages (February 2006)
Mechanisms of the proteinuria induced by Rho GTPases
Volume 63, Issue 6, Pages (June 2003)
Volume 75, Issue 4, Pages (February 2009)
Expression of HIV transgene aggravates kidney injury in diabetic mice
Volume 83, Issue 6, Pages (June 2013)
Volume 77, Issue 11, Pages (June 2010)
Volume 86, Issue 2, Pages (August 2014)
Volume 69, Issue 1, Pages (January 2006)
Volume 87, Issue 2, Pages (February 2015)
Autophagy in proximal tubules protects against acute kidney injury
Volume 80, Issue 1, Pages (July 2011)
Volume 93, Issue 1, (January 2018)
Volume 67, Issue 1, Pages (January 2005)
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 74, Issue 11, Pages (December 2008)
Volume 68, Issue 4, Pages (October 2005)
Volume 82, Issue 7, Pages (October 2012)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Liming Wang, Jae-Hyung Chang, Anne F. Buckley, Robert F. Spurney 
Volume 63, Issue 4, Pages (April 2003)
Targets to retard the progression of diabetic nephropathy
Volume 70, Issue 3, Pages (August 2006)
Volume 67, Issue 2, Pages (February 2005)
Volume 78, Issue 11, Pages (December 2010)
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Glomerular injury is exacerbated in diabetic integrin α1-null mice
Prevention of mesangial sclerosis by bone marrow transplantation
Volume 68, Issue 6, Pages (December 2005)
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
Volume 83, Issue 6, Pages (June 2013)
Volume 75, Issue 7, Pages (April 2009)
LncRNA ZEB1-AS1 Was Suppressed by p53 for Renal Fibrosis in Diabetic Nephropathy  Juan Wang, Jian Pang, Huiling Li, Jie Long, Fang Fang, Junxiang Chen,
Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress  Marjorie E. Dunlop,
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
Volume 81, Issue 8, Pages (April 2012)
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
J. Ma, A. Weisberg, J.P. Griffin, D.E. Vaughan, A.B. Fogo, N.J. Brown 
Volume 80, Issue 9, Pages (November 2011)
Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease  T.A.O. Jiang,
Presentation transcript:

Volume 82, Issue 11, Pages 1176-1183 (December 2012) Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice  Huifang Cheng, Hanmin Wang, Xiaofeng Fan, Paisit Paueksakon, Raymond C. Harris  Kidney International  Volume 82, Issue 11, Pages 1176-1183 (December 2012) DOI: 10.1038/ki.2012.248 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 1 High glucose increased bovine serum albumin (BSA) permeability and apoptosis in glomerular endothelial cells (GEnCs); these effects were inhibited by sepiapterin or l-arginine. (a) High glucose (HG), but not mannitol, increased permeability in GEnCs, indicated by BSA clearance at 5–40min. *P<0.05 HG versus normal medium (NG) or osmolality control (mannitol at same concentration). (b) Sepiapterin (Sep) and l-arginine (l-arg) attenuated HG increases in permeability, *P<0.05 HG versus normal medium or HG with Sep or l-arg coincubation. (c) Effect of HG on apoptosis in GEnCs. Representative images of terminal transferase dUTP nick-end labeling (TUNEL) assay from four independent experiments. (d) Sep and l-arg prevented HG-induced apoptosis. *P<0.05 HG versus normal medium or HG with Sep or l-arg coincubation. Kidney International 2012 82, 1176-1183DOI: (10.1038/ki.2012.248) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 2 Sepapterin (Sep) and l-arginine (l-arg) reversed high glucose–induced endothelial nitric oxide synthase (eNOS) impairment in glomerular endothelial cells (GEnCs). (a) High glucose did not alter eNOS expression, but decreased eNOS dimerization in GEnCs, which could be prevented by Sep or l-arg. Representative photo from three independent experiments. (b) High glucose decreased eNOS phosphorylation at Ser1179, without significant change at Thr479. Sep or l-arg coincubation reversed phosphorylation at Ser1179. Representative photo from three independent experiments. (c) High glucose reduced nitrate/nitrite production by GEnCs, which was corrected by supplementation with Sep or l-arg. *P<0.05 compared with normal medium or high glucose with Sep or l-arg. HG, high glucose; NG, normal glucose. Kidney International 2012 82, 1176-1183DOI: (10.1038/ki.2012.248) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 3 Sepiapterin (Sep) and l-arginine (l-arg) attenuated renal injury in db/db mice. (a) The upper panel indicates glomerular mesangial expansion in db/db mice at 34 weeks by Periodic Acid Schiff staining, Bars: 20μm; the lower panel indicates glomerular basement membrane (GBM) thickness and foot process effacement (red arrow) in db/db mice with or without treatment with Sep/l-arg, bars: 2μm. (b) GBM thickness. *P<0.05, compared with wild-type BKS; #P<0.05, versus each treatment. (c) Sep or l-arg decreased albuminuria in db/db mice at 34 weeks of age. *P<0.05, compared with wild-type BKS; #P<0.05, versus each treatment. (d) Sep or l-arg had no effect on hyperfiltration seen in db/db mice, determined by fluorescein isothiocyanate-inulin clearance. *P<0.05, BKS versus db/db mice regardless of treatments. (e) Sep or l-arg decreased elevations in urine isoprostane excretion in db/db mice. *P<0.05, compared with wild-type BKS; #P<0.05, versus each treatment. (f) Increased nitrotyrosine accumulation in db/db mice was attenuated by Sep or l-arg treatment. Representative photo from three independent experiments. GFR, glomerular filtration rate. Kidney International 2012 82, 1176-1183DOI: (10.1038/ki.2012.248) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 4 Sepiapterin (Sep) and l-arginine (l-arg) reversed endothelial nitric oxide synthase (eNOS) impairment in db/db mice. (a) No significant differences in glomerular eNOS expression were detected between BKS and db/db mice with or without treatment. (n=4; NS). (b) There was decreased eNOS dimerization in glomeruli from db/db mice, which was corrected by administration of Sep or l-arg (n=4, *P<0.05, compared with wild-type or treated groups). (c) There was decreased eNOS phosphorylation at Ser1179, but not at Thr479, in glomeruli from db/db mice and normalization by Sep/l-arg treatment. Representative photo was from three independent experiments. Kidney International 2012 82, 1176-1183DOI: (10.1038/ki.2012.248) Copyright © 2012 International Society of Nephrology Terms and Conditions